Ziekenhuis Netwerk Antwerpen (ZNA)
Welcome,         Profile    Billing    Logout  
 8 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lybaert, Willem
SAUNA, NCT05701241: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Recruiting
4
270
Europe
Somatostatin analog, lanreotide, octreotide, sandostatin, somatuline
University Hospital, Antwerp, Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre
Gastroenteropancreatic Neuroendocrine Tumor
04/29
04/34
XRAY VISION, NCT05386550 / 2022-001144-18: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants

Terminated
3
166
Europe, Canada, Japan, US, RoW
Xevinapant (Debio 1143), IMRT, Placebo
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Head and Neck Cancer
08/24
08/24
ProBio, NCT03903835 / 2018-002350-78: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Recruiting
3
750
Europe
Enzalutamide Oral Capsule, Xtandi, Abiraterone Oral Tablet, Zytiga, Carboplatin, Cabazitaxel 60 mg Solution for Injection, Docetaxel Injectable Solution, Radium Chloride Ra-223, Xofigo, Niraparib plus Abiraterone acetate plus Prednisone, Akeega, Capivasertib plus Docetaxel, Apalutamide, Erleada, Darolutamide, Nubeqa
Karolinska Institutet, The Swedish Research Council, Kom Op Tegen Kanker, Janssen Pharmaceutica N.V., Belgium, AstraZeneca, Cancerfonden
Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
12/26
12/26
KEYNOTE-C34, NCT04811027: Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Checkmark Initiation of TACTI-003 trial in combination with Keytruda for 1L HNSCC
Oct 2021 - Oct 2021: Initiation of TACTI-003 trial in combination with Keytruda for 1L HNSCC
Active, not recruiting
2
171
Europe, US, RoW
eftilagimod alpha, IMP321, efti, eftilagimod alfa, pembrolizumab (KEYTRUDA®), MK-3475
Immutep S.A.S., Merck Sharp & Dohme LLC
HNSCC
03/24
03/25
HyperlynX, NCT06056310: Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN

Terminated
1
18
Europe, US, RoW
Xevinapant, Debio 1143, Cisplatin, intensity-modulated radiation therapy (IMRT)
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Head and Neck Cancer
08/24
08/24
BE-FORCE, NCT06541080: Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the Consortium

Recruiting
N/A
550
Europe
Shallow Whole Genome Sequencing (sWGS)-GIPXplore, methylation-sensitive restriction enzymes (MSRE)-Single-molecule molecular inversion probes (smMIP)-seq assay
University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Universiteit Antwerpen, KU Leuven
Neuroendocrine Neoplasms
12/28
12/30
NCT04641676: A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

Recruiting
N/A
1000
Europe
NGS testing
The Belgian Society of Medical Oncology, Foundation Medicine, Sciensano, Roche Pharma AG
Metastatic Cancer, Local Tumor Invasion
09/22
12/22
REAL-V, NCT05033158: The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.

Completed
N/A
402
Europe
Blood sampling
University Hospital, Antwerp, KomOpTegenKanker (non-profit organization)
Cancer
12/22
06/23
NCT03873103: The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment

Recruiting
N/A
1000
Europe
The Belgian Society of Medical Oncology
Metastatic Cancer
12/23
12/23
NCT05268952: A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Recruiting
N/A
100
Europe, RoW
Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
University Hospital, Antwerp, Universiteit Antwerpen
Neuroendocrine Tumors
05/25
12/25
SHAPERS, NCT06052332: Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer

Recruiting
N/A
230
Europe
Short course radiotherapy, Adjuvant chemotherapy (optional), Total mesorectal excision, Total neoadjuvant therapy
Jules Bordet Institute
Locally Advanced Rectal Cancer, Older People
12/29
12/33
Quali-NET, NCT05268783: Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

Recruiting
N/A
1000
Europe
EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey
University Hospital, Antwerp
Quality of Life
12/29
12/29

Download Options